Won Jin Ho

Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity

Won Jin Ho, Qingfeng Zhu, Jennifer N. Durham et al. · Nature Cancer · 2021 · 346 citations · Full text

Medicine, Oncology, Pharmacology +17

Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival

Ludmila Danilova, Won Jin Ho, Qingfeng Zhu et al. · Cancer Immunology Research · 2019 · 263 citations · Full text

Medicine, Immunology, Oncology +17

Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid Tumors

Kaysia Ludford, Won Jin Ho, Jane V. Thomas et al. · Journal of Clinical Oncology · 2023 · 193 citations · Full text

Medicine, Molecular Genetics, Oncology +15

Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities

Ilias Christodoulou, Won Jin Ho, Andrew Marple et al. · Journal for ImmunoTherapy of Cancer · 2021 · 161 citations · Full text

Life Sciences, Immunology, Oncology +17

Association between pretreatment lymphocyte count and response to PD1 inhibitors in head and neck squamous cell carcinomas

Won Jin Ho, Mark Yarchoan, Alex Hopkins et al. · Journal for ImmunoTherapy of Cancer · 2018 · 129 citations · Full text

Life Sciences, Immunology, Oncology +14